iRhythm Technologies, Inc. (IRTC) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, iRhythm Technologies reported revenue of $747.1M, up 26.2% from $591.8M the year before. Net income was -$44.6M (a -6.0% net margin), or -$1.39 per diluted share. Gross margin was 70.6% and operating margin was -7.7%. Operating activities generated $80.9M of cash, leaving $34.5M of free cash flow. At fiscal year end, iRhythm Technologies held $1.02B in total assets against $867.3M in total liabilities, including $236.0M of cash and equivalents.
Open the full interactive iRhythm Technologies financials → Quarterly statements, key ratios, valuation history and price charts.
iRhythm Technologies Key Stats
| Share Price | $107.71 |
|---|---|
| Market Cap | $3.54B |
| Revenue YoY Growth | +26.2% |
| 52-Week Range | $101.79 – $189.25 |
| Shares Outstanding | 32.9 million (basic, 2026 Q2) |
iRhythm Technologies Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $265.2M | $322.8M | $410.9M | $492.7M | $591.8M | $747.1M |
| Gross Profit | $194.9M | $213.6M | $281.6M | $331.8M | $407.5M | $527.2M |
| Operating Income | -$43.7M | -$99.9M | -$113.8M | -$125.2M | -$115.5M | -$57.4M |
| Pre-Tax Income | -$43.6M | -$101.0M | -$115.9M | -$122.7M | -$112.7M | -$43.6M |
| Income Tax | $229,000 | $367,000 | $269,000 | $750,000 | $565,000 | $953,000 |
| Net Income | -$43.8M | -$101.4M | -$116.2M | -$123.4M | -$113.3M | -$44.6M |
| Diluted EPS | -$1.58 | -$3.46 | -$3.88 | -$4.04 | -$3.63 | -$1.39 |
iRhythm Technologies Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $192.9M | $208.9M | $199.4M | $224.2M |
| Net Income | -$5.2M | $5.6M | -$13.9M | -$381,000 |
| Diluted EPS | -$0.16 | $0.17 | -$0.43 | -$0.01 |
iRhythm Technologies Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $88.6M | $127.6M | $78.8M | $36.2M | $419.6M | $236.0M |
| Current Assets | $377.8M | $305.5M | $288.8M | $230.8M | $645.8M | $702.8M |
| Total Assets | $511.7M | $463.0M | $448.2M | $433.1M | $931.4M | $1.02B |
| Current Liabilities | $65.7M | $87.9M | $89.1M | $107.4M | $110.9M | $151.9M |
| Total Long-Term Debt | $21.3M | $21.4M | $34.9M | $35.0M | $646.4M | $649.5M |
| Total Liabilities | $170.1M | $183.5M | $208.4M | $223.0M | $840.5M | $867.3M |
| Shareholders' Equity | $341.6M | $279.5M | $239.8M | $210.1M | $90.9M | $152.7M |
iRhythm Technologies Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$13.8M | -$37.8M | -$23.0M | -$50.1M | $3.4M | $80.9M |
| Cash From Investing | -$132.4M | $105.3M | -$52.4M | -$1.2M | -$123.0M | -$277.1M |
| Cash From Financing | $214.3M | -$28.6M | $26.7M | $8.8M | $511.4M | $12.6M |
| Free Cash Flow | -$27.3M | -$65.8M | -$52.8M | -$90.5M | -$30.6M | $34.5M |
Figures from iRhythm Technologies' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full iRhythm Technologies financials page for every line item.
iRhythm Technologies Company Profile
| Ticker | IRTC |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | San Francisco, California |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001388658 |
Frequently Asked Questions
What was iRhythm Technologies' revenue in fiscal 2025?
iRhythm Technologies (IRTC) reported revenue of $747.1M for fiscal 2025.
What is iRhythm Technologies' annual revenue history?
iRhythm Technologies' annual revenue by fiscal year: 2020: $265.2M; 2021: $322.8M; 2022: $410.9M; 2023: $492.7M; 2024: $591.8M; 2025: $747.1M.
What was iRhythm Technologies' net income in fiscal 2025?
iRhythm Technologies reported net income of -$44.6M for fiscal 2025.
What was iRhythm Technologies' earnings per share (EPS) in fiscal 2025?
iRhythm Technologies' diluted EPS was -$1.39 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did iRhythm Technologies generate in fiscal 2025?
iRhythm Technologies generated $34.5M of free cash flow in fiscal 2025.
What was iRhythm Technologies' revenue last quarter?
In its most recent reported quarter (2026 Q2), iRhythm Technologies reported revenue of $224.2M.
How much debt does iRhythm Technologies have?
iRhythm Technologies reported $649.5M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of iRhythm Technologies are outstanding?
iRhythm Technologies reported a weighted average of 32.9 million basic shares outstanding in 2026 Q2.
What is iRhythm Technologies' market cap?
Based on its latest closing price, iRhythm Technologies (IRTC) has a market capitalization of about $3.54B.
When does iRhythm Technologies' fiscal year end?
iRhythm Technologies' fiscal year end, as registered with the SEC, is December 31.
Where is iRhythm Technologies headquartered?
iRhythm Technologies lists its business address in San Francisco, California in its SEC filings.